ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

ARWR Arrowhead Pharmaceuticals Inc

25.13
0.13 (0.52%)
Last Updated: 09:46:21
Delayed by 15 minutes

Period:

Draw Mode:

Volume 48,714
Bid Price 25.03
Ask Price 25.14
News -
Day High 25.14

Low
20.67

52 Week Range

High
39.83

Day Low 24.5667
Company Name Stock Ticker Symbol Market Type
Arrowhead Pharmaceuticals Inc ARWR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.13 0.52% 25.13 09:46:21
Open Price Low Price High Price Close Price Prev Close
24.95 24.5667 25.14 25.00
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
227 48,714 $ 24.94 $ 1,214,942 - 20.67 - 39.83
Last Trade Time Type Quantity Stock Price Currency
09:46:24 9 $ 25.14 USD

Arrowhead Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
3.1B 123.90M - 240.74M -205.28M -1.66 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Arrowhead Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ARWR Message Board. Create One! See More Posts on ARWR Message Board See More Message Board Posts

Historical ARWR Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week25.4825.6421.6523.071,795,246-0.35-1.37%
1 Month22.5225.6421.3923.371,089,4472.6111.59%
3 Months30.2536.7221.3927.791,251,242-5.12-16.93%
6 Months26.2939.8320.6729.431,418,843-1.16-4.41%
1 Year37.8239.8320.6729.761,179,546-12.69-33.55%
3 Years72.3293.6620.6739.06949,245-47.19-65.25%
5 Years19.2093.6618.8242.401,147,7795.9330.89%

Arrowhead Pharmaceuticals Description

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

Your Recent History

Delayed Upgrade Clock